Sulphoevernan, a polyanionic polysaccharide, and the narcissus lectin potently inhibit human immunodeficiency virus infection by binding to viral envelope protein

References

1. Baba M., Pauwels R., Balzarini J., Arnout J., Desmyter J., De Clercq E. 1988; Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro . Proceedings of the National Academy of Sciences, U.S.A 85:6132–6136
   [Google Scholar]
2. Baba M., Pauwels R., Balzarini J., Desmyter J., De Clercq E. 1989; Antiviral activity of heparin and dextran sulfate against human immunodeficiency virus (HIV) in vitro . Annals of the New York Academy of Science 556:419–421
   [Google Scholar]
3. Bagasra O., Lischner H. W. 1988; Activity of dextran sulfate and other polyanionic polysaccharides against human immunodeficiency virus. Journal of Infectious Diseases 158:1084–1087
   [Google Scholar]
4. Biesert L., Suhartono H., Winkler J., Meichsner C., Helsberg M., Hewlett Gl., Klimetzek V., Mölling K., Schlumberger H. D., Schrinner E., Brede H. D., Rübsamen-Waigmann H. 1988; Inhibition of HIV and virus replication by polysulphated polyxylan: HOE/BAY 946, a new antiviral compound. AIDS 2:449–457
   [Google Scholar]
5. Cohen S. S. 1987; Antiretroviral therapy for AIDS. New England Journal of Medicine 317:629
   [Google Scholar]
6. Dalgleish A. G., Beverley P. C. L., Clapham P. R., Crawford D. H., Greaves M. P., Weiss R. A. 1984; The CD4 antigen is an essential component of the receptor for the AIDS retrovirus. Nature; London: 312:763–767
   [Google Scholar]
7. Ezekovitz R. A., Kuhlman M., Groopman J. E., Byrn R. A. 1989; A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. Journal of Experimental Medicine 169:185–196
   [Google Scholar]
8. Fennie C., Lasky L. A. 1989; Model for intracellular folding of the human immunodeficiency virus type 1 gpl20. Journal of Virology 63:639–646
   [Google Scholar]
9. Fischl M. A., Richman O. D., Grieco M. H., Gottlieb M. S., Volberding P. A., Laskin O. L., Leedom J. M., Groopman J. E., Mildvan D., Schooley R. T. 1987; The efficacy of azidothymi-dine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. New England Journal of Medicine 317:185–191
   [Google Scholar]
10. Garry R. F. 1989; Potential mechanisms for the cytopathic properties of HIV. AIDS 3:683–694
    [Google Scholar]
11. Geyer H., Holschbach C., Hunsmann G., Schneider J. 1988; Carbohydrates of human immunodeficiency virus. Journal of Biological Chemistry 263:11760–11767
    [Google Scholar]
12. Harada S., Koyanagi Y., Yamamoto N. 1985; Infection of HTLV-III/LAV in HTLV-I-carrying MT-2 and MT-4 and applica-tion in a plaque assay. Science 229:563–566
    [Google Scholar]
13. Henderson D. K., Gerberding J. L. 1989; AIDS commentary. Journal of Infectious Diseases 160:321–327
    [Google Scholar]
14. Kanki P., Barin F., Essex M. 1988; Antibody reactivity to multiple HIV-2 isolates. Fourth International Conference on AIDS, Stockholm abstract 1659
    [Google Scholar]
15. Klatzmann D., Champagne E., Chamaret S., Gruest J., Guetard D., Hercend T., Gluckman J. C., Montagnier L. 1984; T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature; London: 312767–768
    [Google Scholar]
16. Kong L. I., Lee S. W., Kappes J. C., Parkin J. S., Decker D., Hoxie J. A., Hahn B. H., Shaw G. M. 1988; West African HIV-2-related human retrovirus with attenuated cytopathicity. Science 240:1525–1529
    [Google Scholar]
17. Lifson J., Contré S., Huang E., Engleman E. 1986; Role of envelope glycoprotein carbohydrate in human immunodeficiency virus (HIV) infectivity and virus-induced cell fusion. Journal of Experimental Medicine 164:2101–2106
    [Google Scholar]
18. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. 1951; Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193:265–275
    [Google Scholar]
19. Matthews T. J., Weinhold K. J., Lyerly H. K., Langlois A. J., Wigzell H., Bolognesi D. P. 1987; Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gpl20 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. Proceedings of the National Academy of Sciences, U.S.A 84:5424–5428
    [Google Scholar]
20. Mitsuya H., Broder S. 1986; Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotropic virus type III/ lymphadenopathy-associated virus (HTLV-III/LAV) by 2′,3′- dideoxynucleosides. Proceedings of the National Academy of Sciences, U.S.A 83:1911–1915
    [Google Scholar]
21. Mitsuya H., Looney D. J., Kuno S., Ueno R., Wong-Staal F., Broder S. 1988; Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4⁺ cells. Science 240:646–649
    [Google Scholar]
22. Mizuochi T., Spellman M. W., Larkin M., Solomon J., Basa L. J., Feizi T. 1988; Carbohydrate structures of human-immunodeficiency virus (HIV) recombinant envelope glycoprotein gpl20 produced in Chinese hamster ovary cells. Biochemical Journal 254:599–603
    [Google Scholar]
23. Müller W. E. G., Rohde H. J., Steffen R., Maidhof A., Lachmann M., Zahn R. K., Umezawa H. 1975; Influence of formycin-B on polyadenosine diphosphoribose synthesis in vitro and in vivo . Cancer Research 35:3673–3681
    [Google Scholar]
24. Müller W. E. G., Schuster D. K., Zahn R. K., Maidhof A., Leyhausen G., Falke D., Koren R., Umezawa H. 1982; Properties and specificity of binding sites for the immunomodulator bestatin on the surface of mammalian cells. International Journal of Immunopharmacology 4:393–400
    [Google Scholar]
25. Müller W. E. G., Renneisen K., Kreuter M. H., Schröder H. C., Winkler I. 1988a; The d-mannose-specific lectin from Gerardia savaglia blocks binding of human immunodeficiency virus type I to H9 cells and human lymphocytes in vitro . Journal of Acquired Immune Deficiency Syndromes 1:453–458
    [Google Scholar]
26. Müller W. E. G., Sarin P. S., Sun D., Rossol S., Voth R., Rottmann M., Hess G., Meyer Zum Büschenfelde K. H., Schröder H. C. 1988b; Dual biological activity of apurinic acid on human lymphocytes: induction of interferon-γ and protection from human immunodeficiency virus infection in vitro . Antiviral Research 9:191–204
    [Google Scholar]
27. Nara P. L., Fischinger P. J. 1988; Quantitative infectivity assay for HIV-1 and -2. Nature; London: 332469–470
    [Google Scholar]
28. Poiesz B. J., Ruscetti F. W., Gazdar A. F., Bunn P. A., Minna J. D., Gallo R. C. 1980; Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proceedings of the National Academy of Sciences, U.S.A 77:7415–7419
    [Google Scholar]
29. Popović M., Sarngadharan M. G., Read E., Gallo R. C. 1984; Detection, isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497–500
    [Google Scholar]
30. Putney S. D., Matthews T. J., Robey W. G., Lynn D. L., Robert-Guroff M., Mueller W. T., Langlois A. J., Ghrayeb J., Petteway S. R., Weinhold K. J., Fischinger P. J., Wong-Staal F., Gallo R. C., Bolognesi D. P. 1986; HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope. Science 234:1392–1395
    [Google Scholar]
31. Sachs L. 1984 Angewandte Statistik pp. 209–216 Berlin: Springer-Verlag;
    [Google Scholar]
32. Schröder H. C., Wenger R., Kuchino Y., Müller W. E. G. 1989; Modulation of nuclear matrix-associated (2′-5′)oligoadeny- late metabolism and ribonuclease L activity in H9 cells by human immunodeficiency virus. Journal of Biological Chemistry 264:5669–5673
    [Google Scholar]
33. Scudiero D. A., Shoemaker R. H., Paull K. D., Monks A., Tierney S., Nofziger T. H., Currens M. J., Seniff D., Boyd M. R. 1988; Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Research 48:4827–4833
    [Google Scholar]
34. Stefanovich V. 1960 A study of evernan and other components of oak lichen (Evernia prunastri L. Ach.) Ph.D. thesis University of Belgrade;
    [Google Scholar]
35. Stefanovich V. 1969a; The structure and the biological activities of sulfopolyglucans; 1. the biological activity of sulfoevernan. Life Sciences 8:1223–1233
    [Google Scholar]
36. Stefanovich V. 1969b; Cholesterol esterification in rabbit plasma. Biochemical Journal 115:555–561
    [Google Scholar]
37. Stefanovich V., Kajiyama G., Tsutsumi H., Usui S. 1970; The structure and the biological activity of sulfopolyglucans. Part 2. The effect of sulfoevernan and heparin on lipid metabolism. Atherosclerosis 12:349–358
    [Google Scholar]
38. Ueno R., Kuno S. 1987; Dextran sulphate, a potent anti-HIV agent in vitro having synergism with zidovudine. Lancet i:1379
    [Google Scholar]
39. Van Damme E. J. M., Allen A. K., Peumans W. J. 1988; Related mannose-specific lectins from different species of the family Amaryllidaceae . Physiologia Plantarum 73:52–57
    [Google Scholar]
40. Vilmer E., Barre-Sinoussi F., Rouzioux C., Gazengel C., Brun F. V., Dauguet C., Fischer A., Manigne P., Chermann J. C., Griscelli C., Montagnier L. 1984; Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDS. Lancet i:753–757
    [Google Scholar]
41. Wang J. F. 1986; ¹H NMR investigation of the binding of methyl-beta-d-galactose with sialic acid residues on hepatic binding protein - the effect of divalent calcium ions. Scientia Sinaean B 29:156–164
    [Google Scholar]